How much does Rua Life Sciences PLC make?

Rua Life Sciences PLC reported revenue of £6.7m and a loss of £233k in the year to 30 Sep 2025, according to its accounts filed at Companies House.

Is Rua Life Sciences PLC profitable?

No — Rua Life Sciences PLC reported a loss of £233k in the year to 30 Sep 2025.

Company No. SC170071 · Incorporated 21 Nov 1996

Rua Life Sciences PLC

Registered name: RUA LIFE SCIENCES PLC

Rua Life Sciences PLC made £6.7m revenue and a £233k loss in the year to 30 Sep 2025.

Rua Life Sciences PLC’s revenue grew 205% to £6.7m in the year to 30 Sep 2025, with a loss of £233k. The company is classified under “manufacture of medical and dental instruments and supplies” and is based in Irvine; we hold 4 years of its filed accounts.

Full P&L filedSection C · ManufacturingSIC 32500Manufacture of medical and dental instruments and supplies

Status: Active
Location: Irvine, Scotland
Age: 29 yrs · since 1996
Type: Public Limited Company

Latest accounts · year to 30 Sep 2025

Key figures

Independent

Revenue

£6.7m

Growth ▲205.3%

Profit

−£233k

Growth —

Profit margin

−3.5%

Gross 78.5%

Employees

—

Change —

Profit / employee

—

Profitable streak

0yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Mar 2023	31 Mar 2024	30 Sep 2024	30 Sep 2025
Disclosure	Full P&L	Full P&L	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£2.2m	£2.2m	£2.2m	£6.7m
Cost of sales	−£388k	−£415k	−£415k	−£1.4m
Gross profit	£1.8m	£1.8m	£1.8m	£5.3m
Operating profit	−£2.3m	−£1.9m	−£1.9m	−£257k
Profit before tax	−£2.3m	−£2m	−£2m	−£236k
Profit after tax	−£2m	−£1.4m	−£1.4m	−£233k
Profit (best available)	−£2m	−£1.4m	−£1.4m	−£233k
Employees (average)	—	—	—	—
Ratios
Profit margin	−91.9%	−65.7%	−65.7%	−3.5%
Gross margin	82.2%	81.1%	81.1%	78.5%
Growth (year on year)
Revenue growth	—	▲0.5%	—	▲205.3%
Balance sheet — indirect signals, not revenue
Net assets	—	—	—	—
Source	Accounts · bulk data Oct 2024	Accounts · bulk data Oct 2024	Accounts · bulk data Feb 2026	Accounts · bulk data Feb 2026

Derived from the latest filing

How the business works

Profit margin: −3.5%; Profit ÷ revenue.
Gross margin: 78.5%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: —; Revenue ÷ average employees.
Profit per employee: —; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: —; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: —; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: —; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: —; Now —
Cash at bank: —; Now —
Headcount: —; Now —
Deferred income: —; Now —
Fixed assets: —; Now —

Corporate ownership

Group structure

Subsidiaries (5)

Rua Medical Devices LimitedRev. £3.6m · Profit £1.5m
Aortech International LimitedFigures not disclosed
Rua Biomaterials LimitedFigures not disclosed
Rua Structural Heart LimitedFigures not disclosed
Rua Vascular LimitedFigures not disclosed

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from accounts for the year to 30 Sep 2025 (profit −£233k), from the Companies House accounts bulk data published Feb 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.